CDNF [cerebral dopamine neurotrophic factor (NTF)] and GDNF (glial cell line-derived NTF) have shown neuroprotective and neurorestorative effects in rodent and nonhuman primate models of Parkinson’s disease (PD). Here, CDNF is linked to Parkinson disease.